Literature DB >> 30654210

Fabrication of a nanoparticle-containing 3D porous bone scaffold with proangiogenic and antibacterial properties.

Juan L Paris1, Nuria Lafuente-Gómez2, M Victoria Cabañas3, Jesús Román2, Juan Peña2, María Vallet-Regí4.   

Abstract

3D porous scaffolds based on agarose and nanocrystalline apatite, two structural components that act as a temporary mineralized extracellular matrix, were prepared by the GELPOR3D method. This shaping technology allows the introduction of thermally-labile molecules within the scaffolds during the fabrication procedure. An angiogenic protein, Vascular Endothelial Growth Factor, and an antibiotic, cephalexin, loaded in mesoporous silica nanoparticles, were included to design multifunctional scaffolds for bone reconstruction. The dual release of both molecules showed a marked increase in the number of blood vessels on embryonic day 14 in chicken embryos grown ex ovo, while, at the same time providing an antibiotic local concentration capable of inhibiting Staphylococcus aureus bacterial growth. In this sense, different release patterns, monitored by UV-spectroscopy, could be tailored as a function of the cephalexin loading strategy, either releasing all the loaded cephalexin in the first 4 h or less than 50% after 24 h. The scaffold surface was characterized by a high hydrophilicity, with contact angles between 50° and 63°, which enabled the adhesion and proliferation of preosteoblastic cells. STATEMENT OF SIGNIFICANCE: The localized delivery of bioactive molecules has attracted significant attention due to the potential for dose reduction as well as reduced side effects compared to systemic delivery. In this article multifunctional 3D porous scaffolds with a designed porosity have been fabricated. The method also enables the controlled loading of an antibiotic drug and an angiogenic protein into the scaffold. These scaffolds, whose composition resembles the extracellular matrix are suitable for the adhesion of preosteoblast cells, exhibit a sustained cephalexin delivery adequate for inhibiting bacterial growth as well as release the proangiogenic molecule which induces blood vessel formation in chicken embryos grown ex ovo.
Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Agarose; Angiogenic protein; Antibacterial; Mesosoporous silica nanoparticles; Nanoapatite

Mesh:

Substances:

Year:  2019        PMID: 30654210      PMCID: PMC6667335          DOI: 10.1016/j.actbio.2019.01.013

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  52 in total

Review 1.  Current applications of nanoparticles in infectious diseases.

Authors:  Hinojal Zazo; Clara I Colino; José M Lanao
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

Review 2.  Biomimetic Approaches for Bone Tissue Engineering.

Authors:  Johnathan Ng; Kara Spiller; Jonathan Bernhard; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2017-01-18       Impact factor: 6.389

3.  Composite chitosan and calcium sulfate scaffold for dual delivery of vancomycin and recombinant human bone morphogenetic protein-2.

Authors:  Heather A Doty; Megan R Leedy; Harry S Courtney; Warren O Haggard; Joel D Bumgardner
Journal:  J Mater Sci Mater Med       Date:  2014-02-07       Impact factor: 3.896

Review 4.  The relevance of biomaterials to the prevention and treatment of osteoporosis.

Authors:  D Arcos; A R Boccaccini; M Bohner; A Díez-Pérez; M Epple; E Gómez-Barrena; A Herrera; J A Planell; L Rodríguez-Mañas; M Vallet-Regí
Journal:  Acta Biomater       Date:  2014-01-10       Impact factor: 8.947

Review 5.  Micro and nanotechnologies for bone regeneration: Recent advances and emerging designs.

Authors:  Marzieh Mohammadi; Seyed Ali Mousavi Shaegh; Mona Alibolandi; Mohammad Hossein Ebrahimzadeh; Ali Tamayol; Mahmoud Reza Jaafari; Mohammad Ramezani
Journal:  J Control Release       Date:  2018-02-01       Impact factor: 9.776

6.  In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF.

Authors:  Donatella Valdembri; Guido Serini; Angelo Vacca; Domenico Ribatti; Federico Bussolino
Journal:  FASEB J       Date:  2001-12-14       Impact factor: 5.191

7.  Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks.

Authors:  T J Hoerger; K E Downs; M C Lakshmanan; R C Lindrooth; L Plouffe; B Wendling; S L West; R L Ohsfeldt
Journal:  J Womens Health Gend Based Med       Date:  1999-10

Review 8.  Clinical practice. Infection associated with prosthetic joints.

Authors:  Jose L Del Pozo; Robin Patel
Journal:  N Engl J Med       Date:  2009-08-20       Impact factor: 91.245

9.  Mesoporous silicate nanoparticles/3D nanofibrous scaffold-mediated dual-drug delivery for bone tissue engineering.

Authors:  Qingqing Yao; Yangxi Liu; Balaranjan Selvaratnam; Ranjit T Koodali; Hongli Sun
Journal:  J Control Release       Date:  2018-04-09       Impact factor: 9.776

Review 10.  Bone tissue engineering via growth factor delivery: from scaffolds to complex matrices.

Authors:  Tinke-Marie De Witte; Lidy E Fratila-Apachitei; Amir A Zadpoor; Nicholas A Peppas
Journal:  Regen Biomater       Date:  2018-06-09
View more
  12 in total

Review 1.  Scaffolds in the microbial resistant era: Fabrication, materials, properties and tissue engineering applications.

Authors:  Ángel Serrano-Aroca; Alba Cano-Vicent; Roser Sabater I Serra; Mohamed El-Tanani; AlaaAA Aljabali; Murtaza M Tambuwala; Yogendra Kumar Mishra
Journal:  Mater Today Bio       Date:  2022-08-30

Review 2.  Medical Applications of Porous Biomaterials: Features of Porosity and Tissue-Specific Implications for Biocompatibility.

Authors:  Jamie L Hernandez; Kim A Woodrow
Journal:  Adv Healthc Mater       Date:  2022-02-19       Impact factor: 11.092

Review 3.  Natural medicine delivery from biomedical devices to treat bone disorders: A review.

Authors:  Susmita Bose; Naboneeta Sarkar; Dishary Banerjee
Journal:  Acta Biomater       Date:  2021-02-28       Impact factor: 8.947

Review 4.  Polysaccharide-Based Systems for Targeted Stem Cell Differentiation and Bone Regeneration.

Authors:  Markus Witzler; Dominik Büchner; Sarah Hani Shoushrah; Patrick Babczyk; Juliana Baranova; Steffen Witzleben; Edda Tobiasch; Margit Schulze
Journal:  Biomolecules       Date:  2019-12-06

Review 5.  Periosteum and development of the tissue-engineered periosteum for guided bone regeneration.

Authors:  Wentao Zhang; Naiguo Wang; Ming Yang; Tianze Sun; Jing Zhang; Yantao Zhao; Na Huo; Zhonghai Li
Journal:  J Orthop Translat       Date:  2022-02-16       Impact factor: 5.191

6.  Preparation of Multiwall Carbon Nanotubes Embedded Electroconductive Multi-Microchannel Scaffolds for Neuron Growth under Electrical Stimulation.

Authors:  Zhenhui Liu; Maimaiaili Yushan; Yamuhanmode Alike; Yanshi Liu; Shuo Wu; Chuang Ma; Aihemaitijiang Yusufu
Journal:  Biomed Res Int       Date:  2020-04-12       Impact factor: 3.411

Review 7.  Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Pharmaceutics       Date:  2020-01-20       Impact factor: 6.321

8.  Nanostructured selenium-doped biphasic calcium phosphate with in situ incorporation of silver for antibacterial applications.

Authors:  Lei Nie; Mengjuan Hou; Tianwen Wang; Meng Sun; Ruixia Hou
Journal:  Sci Rep       Date:  2020-08-13       Impact factor: 4.379

Review 9.  Hard and Soft Protein Corona of Nanomaterials: Analysis and Relevance.

Authors:  Rafaela García-Álvarez; María Vallet-Regí
Journal:  Nanomaterials (Basel)       Date:  2021-03-31       Impact factor: 5.076

10.  The Role of Transmission Electron Microscopy in the Early Development of Mesoporous Materials for Tissue Regeneration and Drug Delivery Applications.

Authors:  María Luisa Ruiz-González; Almudena Torres-Pardo; José M González-Calbet
Journal:  Pharmaceutics       Date:  2021-12-20       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.